Skip to content
GLP-1 Decoder

Trulicity Long-Term Side Effects: What Years of Data Show

Trulicity has been sold in the US since 2014. The long-term label warnings are thyroid C-cell tumors (seen in rodents), pancreatitis, gallbladder disease and kidney injury from fluid loss.

Sold in the US since
2014
Most common
Nausea 21.1%
Same on placebo
5.3%
Trial group
Adults with type 2 diabetes

Trulicity in brief

How long it remains in the body
100%50%25%0%05 d10 d15 d20 d25 d50%25%12.5%time after the dose

Its half-life is about 5 days. After 5 d, half is gone. After five half-lives (25 d), about 3% remains.

Sources: FDA label (DailyMed).

Serious warnings in plain terms

Source: FDA label (DailyMed).

Source: FDA label (DailyMed).

Trulicity long term side effects: label rates vs placebo

The FDA label lists 7 common Trulicity side effects identified through placebo-controlled trials. The final column shows how much more often each effect occurred than with placebo.

In Table 1, Trial Data covers Type 2 Diabetes Mellitus Adverse Reactions from the Pool of Placebo-Controlled Trials That Occurred in ≥5% of TRULICITY-Treated Adult Patients
Side effectPlaceboTrulicity 0.75 mgTrulicity 1.5 mgMore than placebo, 1.5 mg
Nausea5.3%12.4%21.1%+15.8 points
Vomiting2.3%6%12.7%+10.4 points
Diarrhea6.7%8.9%12.6%+5.9 points
Abdominal Pain4.9%6.5%9.4%+4.5 points
Decreased Appetite1.6%4.9%8.6%+7 points
Dyspepsia2.3%4.1%5.8%+3.5 points
Fatigue2.6%4.2%5.6%+3 points

Source: FDA label (DailyMed).

Which people have more side effects